From: The influence of leukocytospermia on the outcomes of assisted reproductive technology
 | Total | P | Leukocytospermia | P | Non-leukocytospermia | P | |||
---|---|---|---|---|---|---|---|---|---|
 | ICSI | IMSI |  | ICSI | IMSI |  | ICSI | IMSI |  |
Cycles | 50 | 50 | Â | 25 | 25 | Â | 25 | 25 | Â |
Leukocytes in semen (x106)(mean ± SD) | 1.5 ± 1.8 (0–8) | 2.5 ± 7.5 (0–50) | 0.41 | 2.4 ± 1.7 (1–8) | 4.8 ± 10.5(1–50) | 0.10 | 0.4 ± 0.3 (0–0.8) | 0.4 ± 0.3 (0–0.8) | 0.76 |
Female age (years) | 34.4 ± 3.6 | 34.8 ± 3.9 | 0.67 | 34.4 ± 3.8 | 34.8 ± 4.1 | 0.75 | 34.5 ± 3.6 | 34.8 ± 3.8 | 0.79 |
Male age (years) | 36.9 ± 5.0 | 37.2 ± 5.6 | 0.80 | 37.2 ± 5.0 | 37.4 ± 5.2 | 0.91 | 36.7 ± 5.0 | 37.0 ± 6.0 | 0.81 |
Aetiology (%) | Â | Â | 0.10 | Â | Â | 0.43 | Â | Â | 0.26 |
Male | 48% (24/50) | 40% (20/50) | Â | 56% (14/25) | 36% (9/25) | Â | 40% (10/25) | 44% (11/25) | Â |
Idiopathic | 16% (8/50) | 24% (12/50) | Â | 16% (4/25) | 20% (5/25) | Â | 16% (4/25) | 28% (7/25) | Â |
Tuboperitoneal | 10% (5/50) | 16% (8/50) | Â | 12% (3/25) | 24% (6/25) | Â | 8% (2/25) | 8% (2/25) | Â |
Endometriosis | 18% (9/50) | 8% (4/50) | Â | 8% (2/25) | 4% (1/25) | Â | 28% (7/25) | 12% (3/25) | Â |
Tuboperitoneal + endometriosis | 6% (3/50) | ---- |  | 4% (1/25) | ---- |  | 8% (2/25) | --- |  |
Male + tuboperitoneal | 2% (1/50) | 8% (4/50) |  | 4% (1/25) | 8% (2/25) |  | ---- | 8% (2/25) |  |
Male + t endometriosis | ---- | 4% (2/50) |  | ---- | 8% (2/25) |  |  | --- | |
Semen parametersa (mean ± SD) |  |  |  |  |  |  |  |  |  |
Total sperm count (x106/mL) | 56.5 ± 49.5 | 50.9 ± 40.3 | 0.87 | 43.2 ± 44.5 | 41.0 ± 34.8 | 0.70 | 69.7 ± 51.5 | 60.8 ± 43.6 | 0.58 |
Motility (% spermatozoa) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
-rapid + slow\progression | 43.1 ± 19.7 | 51.4 ± 22.2 | 0.09 | 35.8 ± 17.8 | 44.3 ± 21.8 | 0.17 | 50.7 ±17.9 | 58.6 ± 20.8 | 0.22 |
-non-progressive | 11.5 ± 11.4 | 9.6 ± 11.2 | 0.08 | 11.9 ± 12.3 | 10.5 ± 13.7 | 0.17 | 11.2 ± 10.3 | 8.6 ± 8.3 | 0.25 |
-immotile | 42.6 ± 20.6 | 38.6 ± 20.4 | 0.42 | 50.4 ± 23.6 | 45.8 ± 21.0 | 0.50 | 35.9 ± 13.6 | 31.4 ± 17.3 | 0.36 |
Morphology | Â | Â | Â | Â | Â | Â | Â | Â | Â |
-normal forms (%) | 14 ± 10.5 | ---- |  | 10.1 ± 0.8 | ---- |  | 17.9 ± 20.3 | ---- |  |
Vitality (%) | 46.9 ± 19.2 | 44.2 ± 19.6 | 0.66 | 45.1 ± 17.5 | 43.1 ± 20.5 | 0.81 | 48.8 ± 20.9 | 45.3 ± 18.7 | 0.52 |
MSOME b (%) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
-normal spermatozoa | ---- | 1.13 ± 1.65 |  | ---- | 0.92 ± 1.43 |  | ---- | 1.35 ± 1.87 |  |
-spermatozoa with vacuoles occupying >50% of the nuclear area | ---- | 35.9 ± 23.05 |  | ---- | 37.8 ± 20.2 |  |  | 34.0 ± 25.9 |  |
Metaphase II oocytes (n) | 7.8 ± 4.3 | 7.8 ± 5.2 | 0.69 | 8.5 ± 4.2 | 8.2 ± 5.7 | 0.66 | 7.3 ± 4.2 | 7.4 ± 4.9 | 0.81 |
Fertilisation rate (%) | 59.9 ± 28.7 | 63.5 ± 26.5 | 0.55 | 57.9 ± 30.2 | 67.6 ± 24.6 | 0.35 | 61.9 ± 27.7 | 59.5 ± 28.1 | 0.86 |
Embryos transfer (n) | 2.1 ± 0.9 | 2.4 ± 0.8 | 0.21 | 2.2 ± 0.9 | 2.3 ± 0.8 | 0.90 | 2.1 ± 1.0 | 2.6 ± 0.9 | 0.10 |
Implantation rate (%) | 13.2% (14/106) | 17.2% (19/111) | 0.54 | 12.3% (7/54) | 17.5% (10/57) | 0.68 | 13.5% (7/52) | 16.7% (9/54) | 0.84 |
Pregnancy/cycle (%) | 24% (12/50) | 26% (13/50) | 0.81 | 24% (6/25) | 28% (7/25) | 0.74 | 24% (6/25) | 24% (6/25) | 1 |
Miscarriage (%) | 0 | 7.7% (1/13) | 0.32 | 0 | 14.3% (1/7) | 0.33 | 0 | 0 | ---- |
Ongoing pregnancy/cycle (%) | 24% (12/50) | 24% (12/50) | 1 | 24% (6/25) | 24% (6/25) | 1 | 24% (6/25) | 24% (6/25) | 1 |
Live birth/cycle (%) | 24% (12/50) | 24% (12/50) | 1 | 24% (6/25) | 24% (6/25) | 1 | 24% (6/25) | 24% (6/25) | 1 |